C-O6LVHuman Longevity Inc.
genomics, imaging, biomarkers
diagnostics
Loading
Loading section...0-100 chain-logic scale · 15 dimensions · scored on public evidence
←All companiesC-O6LV
C-O6LVC-O6LVgenomics, imaging, biomarkers
0-100 chain-logic scale · 15 dimensions · scored on public evidence
As we start the 2024 New Year, we are thrilled to share a glimpse of a truly special event held in the elegance of our South San Francisco clinic. This gathering was a moment of insight and inspiration, featuring our company's visionary founder, Dr. Craig Venter. In an enlightening segment from the event, Dr. Venter introduced the groundbreaking potential of pre-symptomatic testing in transforming healthcare, shifting the focus from treatment to prevention and the necessity of data-driven change in the medical community, showcasing Human Longevity Inc.'s commitment to revolutionizing healthcare practices. 👉 Watch the full video here : https://www.youtube.com/watch?v=R8Ar7vYNNzg In the full video, Dr. J. Craig Venter delved into the insights of the ocean's microbiome and its impact on genomic research while also sharing the mesmerizing tales of his sailing expedition aboard Sorcerer II. Dr. J. Craig Venter: A visionary biologist, geneticist, and entrepreneur, Dr. J. Craig Venter has
Embark on an extraordinary journey with Human Longevity Inc.'s founder, Dr. J. Craig Venter, as he delves into the depths of the ocean's microbiome in his new book, "The Voyage of Sorcerer II." In this video, Dr. Venter shares mesmerizing tales of his sailing expedition aboard Sorcerer II, a quest that unraveled the mysteries hidden beneath the ocean's surface. Join us as he explores the significance of the microbiome, its impact on human health, and the groundbreaking discoveries made during this pioneering voyage. Video Key Highlights: 🚢 The story behind Sorcerer II's expedition 🌐 Insights into the ocean's microbiome 🌊 The intersection of marine microbiology, human longevity, and genomic research About Dr. J. Craig Venter: A visionary biologist, geneticist, and entrepreneur, Dr. J. Craig Venter has been at the forefront of genomics and synthetic biology. As the founder of Human Longevity Inc., he continues to lead groundbreaking research that aims to extend and improve human l
3rd Kyoto University-Inamori Foundation Joint Kyoto Prize Symposium http://kuip.hq.kyoto-u.ac.jp/ https://ocw.kyoto-u.ac.jp/en/opencourse-en/158 July 9, 2016 [Biotechnology and Medical Technology] J. Craig Venter Human Longevity, Inc. / J. Craig Venter Institute / Synthetic Genomics, Inc. / Doctor Title of Presentation “Human Genomics and the Future of Medicine” In 1995 J. Craig Venter, Ph.D. and team at the Venter Institute sequenced the first genome in history followed five years later when Celera Genomics published the first draft human genome which was a composite of five individual’s genomes. In 2007 he and his team at the J. Craig Venter Institute published the first complete diploid human genome, which was his genome. While these genomes were an important starting point for research, they were not enough to change health care. We need hundreds of thousands to have their own genome sequenced and done so at a complete and accurate level to have sufficient data to interpret the
Sailors' Scuttlebutt Lecture Series, August 22, 2018, at the Nantucket Whaling Museum. Presented in partnership with Nantucket Community Sailing. J. Craig Venter, PhD, is regarded as one of the leading scientists of the 21st century for his numerous invaluable contributions to genomic research. Dr. Venter is Co-Founder, Chairman and Chief Executive Office of Human Longevity, Inc. (HLI), generator of “health intelligence” through the integration of genomics, state-of-the-art imaging and machine learning. He was on the 2007 Time 100 most influential people in the world list made by Time magazine. The Global Ocean Sampling Expedition (GOS) is an ocean exploration genome project with the goal of assessing the genetic diversity in marine microbial communities and to understand their role in nature's fundamental processes. Begun as a Sargasso Sea pilot sampling project in August 2003, Venter announced the full Expedition on 4 March 2004. The project, which used Venter's personal yacht, Sor
3rd Kyoto University-Inamori Foundation Joint Kyoto Prize Symposium http://kuip.hq.kyoto-u.ac.jp/ https://ocw.kyoto-u.ac.jp/en/opencourse-en/158 July 9, 2016 [Biotechnology and Medical Technology] J. Craig Venter Human Longevity, Inc. / J. Craig Venter Institute / Synthetic Genomics, Inc. / Doctor Title of Presentation “Human Genomics and the Future of Medicine” In 1995 J. Craig Venter, Ph.D. and team at the Venter Institute sequenced the first genome in history followed five years later when Celera Genomics published the first draft human genome which was a composite of five individual’s genomes. In 2007 he and his team at the J. Craig Venter Institute published the first complete diploid human genome, which was his genome. While these genomes were an important starting point for research, they were not enough to change health care. We need hundreds of thousands to have their own genome sequenced and done so at a complete and accurate level to have sufficient data to interpret the
(Visit: http://www.uctv.tv/) The Rady School of Management at UC San Diego presents J. Craig Venter, the Co-Founder and Executive Chairman of Human Longevity Inc. as the keynote speaker for its 2017 Michael Kriegler Memorial Lecture. Venter describes in fascinating detail how researchers saved his life by diagnosing his own prostate cancer using new imaging techniques that caught what routine biopsies had missed. Venter shares other stories of breakthroughs that demonstrate how genomics-based technology is transforming the practice of medicine. Venter is introduced by Ashley Van Zeeland, a Rady alumna with significant experience leading innovative scientific programs, including groundbreaking work in the genetics of autism, neurodevelopmental disorders and other rare genetic pediatric diseases. [3/2017] [Public Affairs] [Health and Medicine] [Science] [Business] [Show ID: 31915]
Human Longevity | Early Detection for a Longer Life About About Us → Our mission, team, and story. Team → The scientists, physicians, and engineers behind HLI. Press → Media coverage, press releases, and news. Programs Programs Overview → Compare Genomics for All, Executive Health, and 100+ Care. Genomics → Clinical-grade whole genome sequencing — 6.4B base pairs, AI-interpreted. Executive Health → Full-body MRI, 120+ biomarkers, genome sequencing in one comprehensive visit. 100+ Care → Ongoing physician-led care with advanced diagnostics and longitudinal follow-up. Education Member Portal Get
J. Craig Venter - Precision Medicine and the Future of Healthcare Skip to main content Search Type to search or ESC to close Close Search search Menu MEMBERSHIP About Membership Thought Leadership Apply for Membership CONVENINGS SEMI-ANNUAL EVENTS CONNECT Sept 27-29, 2026 | Nashville, TN SUMMIT April 6-8, 2027 | Laguna Niguel, CA YEAR-ROUND PROGRAMMING FORUM Leaders Driving Innovation Year-Round FORUM ROUNDTABLES Integrated Home-Based Care Achieving Consumer-Centric Care Experiences Value-Based Care For Specialized Populations Transforming Health Care Economics Catalyzing Action to Advance Hea … d Discovery Organizational Transformation PARTNERSHIP Partners ABOUT US Careers APPLY TO CONNECT search Apply for Membership MEMBERSHIP About Membership Thought Leadership Apply for Membership CONVENINGS SEMI-ANNUAL EVENTS CONNECT Sept 27-29, 2026 | Nashville, TN SUMMIT April 6-8, 2027 | Laguna Niguel, CA YEAR-ROUND PROGRAMMING FORUM Leaders Driving Innovation Year-Round FORUM ROUNDTABLES Integrated Home-Based Care Achieving Consumer-Centric Care Experiences Value-Based Care … d Discovery Organizational Transformation PARTNERSHIP Partners ABOUT US Careers APPLY TO CONNECT Discussion Leader - Sharing insights, inspiring change - J. Craig Venter, PhD Co-founder, Executive Chairman & CEO Human Longevity Inc. J. Craig Venter, a biologist renowned for his contributions in sequencing the first draft human genome in 2001, is co-founder, executive chairman and CEO of Human Longevity Inc. He is also founder, executive chairman and CEO of the J. Craig Ve … SUMMIT | APRIL 4-6 CONNECT | SEPTEMBER 25-27 INTERESTED IN JOINING MEMBERSHIP? APPLY HERE QUESTIONS? CONTACT US © 2026 Health Evolution. All Rights Reserved. Privacy Policy Terms of Use Media Guidelines X Footer Contact Form " * " indicates required fields Your Name * Your Email * Organization * Burning question? Let us know! * CAPTCHA
Genentech and Human Longevity Inc. announce multi-year agreement - The Cancer Letter Skip to navigation Skip to content Search for: The Cancer Letter on Facebook The Cancer Letter on Twitter The Cancer Letter on LinkedIn The Cancer Letter The leading source for information on the issues that shape oncology since 1973 Home About Our Readers Our History Our Contributors Contact Us Store Current Issue Past Issues Podcast The Directors Events Job Board SUBSCRIBE Login SUBSCRIBE Login Search for: Home About Our Readers Our History Our Contributors Contact Us Store Current Issue Past Issues Podcast … e acquires Bina Technologies Inc. Karmanos Cancer Institute receives $5 million grant from the Dresner Foundation ASCO and College of American Pathologists announce partnership Mount Sinai Health System and Valley Health System announce collaboration Pelotonia awards six grants to Ohio State Genentech and Human Longevity Inc. announce multi-year agreement MD Anderson, Intrexon, and Ziopharm announce sublicensing agreement with the University of Minnesota Amgen and MD Anderson … g back “The question isn’t whether politics will influence research. Under this proposal, that’s the point. That’s their goal.” The White House Office of Management and Budget has published a “Regulation for Federal Financial Assistance,” a proposed rule that seeks to fundamentally redraw the ground rules for all federally funded research. On the other side are America’s scientists who aren’t just crying foul—they are readying for a political fight. June 12, 2026 Vol.52 No.23 … e 12, 2026 Vol.52 No.23 By Saro Armenian Cancer Policy NIH calls for comment on proposal to limit the number of RPGs per PI NIH has published a request for information on its proposed policy that would cap the number of research project grants, or RPGs, for which an individual can simultaneously serve as principal investigator or multi-principal investigator. June 12, 2026 Vol.52 No.23 By Jacquelyn Cobb ABOUT ABOUT About The Cancer Letter Accessibility Statement Our Contribut … e acquires Bina Technologies Inc. Karmanos Cancer Institute receives $5 million grant from the Dresner Foundation ASCO and College of American Pathologists announce partnership Mount Sinai Health System and Valley Health System announce collaboration Pelotonia awards six grants to Ohio State Genentech and Human Longevity Inc. announce multi-year
NeoGenomics Acquires Oncology Division from Human Longevity for $37 Million :: NeoGenomics, Inc. (NEO) NeoGenomics to Present New Research at ASCO Annual Meeting 2026 NeoGenomics to Participate in Upcoming Investor Conferences NeoGenomics Reports First Quarter 2026 Results NeoLINK Login Investors Contact Us Search NeoLINK Login Menu Home Providers Providers Oncology solutions RaDaR ST MRD PanTracer portfolio Lung cancer Breast cancer Colorectal cancer Gastric cancer Gynecologic cancer Hematologic cancers Pathology solutions Test search Lab services Client support & resources EHR Integratio
Human Longevity, Discovery to Offer Clients Sequencing, Analysis for $250 clinicalomicsprowebdirectory Facebook Linkedin Twitter News Topics Informatics Molecular Dx Patient Care Oncology Precision Medicine Translational Research Magazine Browse Issues Subscribe Subscribe Get Inside Precision Medicine Magazine Get Inside Precision Medicine eNewsletters Multimedia Webinars Summits Podcasts Videos Inside Precision Medicine Live Learning Labs eBooks Search Facebook Linkedin Twitter Sign in Welcome! Log into your account your username your password Forgot your password? Get help Privacy Policy Pas
Based on a study recently... - Human Longevity, Inc. Facebook Вход Публикация Human Longevity, Inc. Human Longevity, Inc. 23 май 2022 г. · Поделился/-ась с Доступно всем Based on a study recently published in the British Medical Journal, healthy eating, daily exercise, reducing alcohol consumption, and not smoking not only lead to a longer life, but can also reduce #Alzheimer ’s risk. The research found that people ages 65 and older who had a healthy lifestyle lived longer—3.1 years longer for women, 5.7 years longer for men—than their peers who didn’t have the same healthy lifestyle. They als
Human Longevity - PMWC Precision Medicine World Conference Chat with us , powered by LiveChat Skip to content Chats Contact Speakers Agenda Tickets Menu FULL MENU FULL MENU Register here Rates by JUN. 18 Register here PMWC, Jan 25-27, 2023 PMWC - Silicon valley, ca January 27-29, 2027 Past Event PMWC, Feb 5-7, 2025 PMWC - Silicon valley, ca January 27-29, 2027 Attend Program Schedule Sessions Honorees Speakers Company Competition Showcases Travel Venue Sightseeing Reduced Rates Hotel Flights Exhibits + Map Login / My Account Participate REGISTER TO EXHIBIT Prospectus Attendee Breakdown Apply t … ogin / My Account Participate Register to Exhibit Prospectus Attendee Breakdown Apply to speak Sponsorship Inquiry GET UPDATES ABOUT Mission Testimonial Past Conferences Past Honorees Past Speakers FAQ CONTACT US Menu agenda speakers exhibits Contact us agenda speakers exhibits Contact us BUY TICKETS SAVE $1366 BY JUN. 18 Menu Item #1 Item #1 PMWC - Silicon valley, ca Jan. 27-29, 2027 Pittsburgh, pa sep. 23-24 PMWC - Silicon valley, ca Jan. 27-29, 2027 Register Here Rates by … tend Program Speakers Travel Exhibits + Map Main Program View your save program Award Reception Speaker gallery Select part speakers Exhibit gallery Part conferences Participate Register to Exhibit Apply to speak Sponsorship Inquiry ABOUT Login / My Account CONTACT US Get Updates Pittsburgh, pa sep. 23-24 Register Here Rates by Attend Program Travel Reduced Rates Exhibits + Map Main Program View your save program Award Reception Paticipate Register to Exibit Apply to speak Sp … nomix Labs Alphaexpeditions Alpine Alquest Therapeutics ALS Emergency Treatment Fund Alta Bates Summit Comprehensive Cancer Center Alta Devices AltaQ Altered Egos Comics AltheaDx Althia Altiora Altis Biosystems, LLC Altoida Inc Altos Labs AltruBio Altum Medical Alum Alumot – sprint Aluna Health Alva10 Alveo Technologies Alverno Laboratories AlwaysRx Alykomed Global Solutions LLC Alykomedglobal Alzheimer’s X Alzheon AMA Ama-Assn Amaro Therapeutics Amazon Amber Health Amb … Y Ancestry Anderson Cancer Center Andreessen Horowitz Andrew Andy Strouse Angel Fund Angel Investor ANGLE Biosciences ANGLE Europe Ltd. ANGLE, plc Angleplc Angstrom Bio Angular Medicine Anima AnjaGen Consulting Anl Annai Systems, Inc Annexon Biosciences Annexon Inc Annexonbio Anocca Ansun Biopharma Antenna Anthem Anthony Pastena, M.D. ,P.C Anthos
Events | Human Longevity Human Longevity Insights Papers Events Press Events Where we’ll be next. Upcoming No upcoming events. Check back soon. © 2026 Human Longevity, Inc. About Contact Privacy Terms
Human Longevity, Inc. Supports Medical Innovation to Advance the Treatment of Cancer and Other Diseases Accessibility Statement Skip Navigation Resources Investor Relations Journalists Agencies Client Login Send a Release News Products Contact Search Search When typing in this field, a list of search results will appear and be automatically updated as you type. Searching for your content... No results found. Please change your search terms and try again. News in Focus Browse News Releases All News Releases All Public Company English-only News Releases Overview Multimedia Gallery All Multimedia … tform Login ProfNet Data Privacy Do not sell or share my personal information : Submit via [email protected] Call Privacy toll-free: 877-297-8921 Contact PR Newswire Products About My Services All News Releases Platform Login ProfNet Call PR Newswire at 888-776-0942 Terms of Use Privacy Policy Information Security Policy Site Map RSS Cookies Copyright © 2026 Cision US Inc. --> -->
🎉 Join Us for an Exclusive Open... - Human Longevity, Inc. Facebook Вход Публикация Human Longevity, Inc. Human Longevity, Inc. 22 июль 2024 г. · Поделился/-ась с Доступно всем Join Us for an Exclusive Open House Event at Human Longevity! We’re thrilled to invite you to an open house at our South San Francisco Clinic! Come and see how we’re revolutionizing preventative care and accelerating the world’s transition to 100+ living. Date: Friday, July 26th Time: 6 PM PST Location: 600 Gateway Blvd, South San Francisco, CA 94080 This is your chance to experience firsthand the cutting-edge advancem
Human Longevity Inc. - TVM Capital Healthcare Investor log in About Strategy Impact Portfolio Team Events News Contact us --> --> Home News Human Longevity Inc. Human Longevity Inc. --> --> --> --> --> --> Human Longevity, Inc. (HLI), based in San Francisco, is a global leader since 2013 in advancing precision medicine in the pursuit of healthy aging, often referred to as longevity medicine. HLI is committed to accelerating living to 100+ by revolutionizing the landscape of the current system of “sickcare” to true “healthcare.” Founded by Dr. J. Craig Venter, one of the pioneers of the human g
- YouTube Info Presse Urheberrecht Kontakt Creator Werben Entwickler Impressum Verträge hier kündigen Nutzungsbedingungen Datenschutz Richtlinien & Sicherheit Wie funktioniert YouTube? Neue Funktionen testen © 2026 Google LLC
In lawsuit, Human Longevity alleges that Craig Venter stole trade secrets Skip to Main Content research NIH global health Newsletters Log In My Account Subscribe Now My Account Settings Complete your personal information for a more tailored experience Billing Log Out A decade of reporting from the frontiers of health and medicine Newsletters Log In My Account Subscribe Now Biotech Pharma Public Health Health Tech Policy Science First Opinion STAT+ STAT Events Search Log In Try STAT+ My Account Home News Latest Series & Investigations Business Biotech Pharma Health Tech Health Insurance Hos … or of the newsletter STAT Health Tech . @rebeccadrobbins Tags genetics legal To submit a correction request, please visit our Contact Us page . Trending WHO director-general is profoundly concerned after visit to Ebola… WHO director-general is profoundly concerned after visit to Ebola outbreak area Are Republicans turning against medications for treating opioid addiction? Are Republicans turning against medications for treating opioid addiction? The history of OxyConti … or HHS Advertisement Politics Anil Oza STAT Plus: Scientists see promise in NIH proposal to cap number of grants they receive Biotech Andrew Joseph STAT Plus: Combination of pancreatic cancer drugs from Tango, Revolution leads to high response rate Exclusive Casey Ross and Bob Herman STAT Plus: Private Medicare plans erect barriers to rehab care in pursuit of profit, federal investigators find A decade of reporting from the frontiers of health and medicine Back to top Company
Human Longevity, Inc. Sues J. Craig Venter Institute Over Trade Secrets - BioSpace News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy Cancer Opinions Press Releases All News & Releases Podcasts Events Jobs Companies Hotbeds More Reports Career Advice NextGen: Top Startups to Watch 40 Under 40 Best Places to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event SUBSCRIBE Menu SUBSCRIBE Show Search News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy Cancer Opinions … laces to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event Search Query Submit Search News Policy Human Longevity, Inc. Sues J. Craig Venter Institute Over Trade Secrets July 23, 2018 | 3 min read | Mark Terry Twitter LinkedIn Facebook Email Print lawsuit form with filler and book eccolo74/Getty Images/iStockphoto La Jolla, California-based Human Longevity, Inc. (HLI) filed a l … Policy RSS Feeds Advertise Employer Login Post Jobs Talent Solutions Advertise Submit a Press Release Submit an Event © 1985 - 2026 BioSpace.com. All rights reserved. twitter instagram facebook linkedin
Honoring Dr. J. Craig Venter's Legacy, Human Longevity Launches Clinical-Grade $599 Whole Genome Sequencing Report with AI-Enhanced Insights for Proactive Disease Prevention Accessibility Statement Skip Navigation Resources Investor Relations Journalists Agencies Client Login Send a Release News Products Contact Search Search When typing in this field, a list of search results will appear and be automatically updated as you type. Searching for your content... No results found. Please change your search terms and try again. News in Focus Browse News Releases All News Releases All Public Company … tform Login ProfNet Data Privacy Do not sell or share my personal information : Submit via [email protected] Call Privacy toll-free: 877-297-8921 Contact PR Newswire Products About My Services All News Releases Platform Login ProfNet Call PR Newswire at 888-776-0942 Terms of Use Privacy Policy Information Security Policy Site Map RSS Cookies Copyright © 2026 Cision US Inc. --> -->